Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this observational study is to evaluate safety,
efficacy and convenience in using NovoMix® 30 FlexPen® in type 2 diabetes under normal
clinical practice conditions.